US Stock MarketDetailed Quotes
CNTB Connect Biopharma
- 1.1400
- +0.1700+17.53%
Close Dec 27 16:00 ET
- 1.1400
- 0.00000.00%
Post 17:06 ET
62.82MMarket Cap-2.92P/E (TTM)
1.2000High0.9300Low81.48KVolume0.9700Open0.9700Pre Close84.47KTurnover0.56%Turnover RatioLossP/E (Static)55.10MShares2.660052wk High0.57P/B16.69MFloat Cap0.900052wk Low--Dividend TTM14.64MShs Float29.2735Historical High--Div YieldTTM27.84%Amplitude0.5347Historical Low1.0360Avg Price1Lot Size
About Connect Biopharma Company
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
Company Profile
SymbolCNTB
Company NameConnect Biopharma
Listing DateMar 19, 2021
Issue Price17.00
Founded2015
CEODr. Zheng Wei, PhD
MarketNASDAQ
Employees81
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressScience & Technology Park,3/F, East R&D Building,6 Beijing West Road
CityTaicang
ProvinceJiangsu
CountryChina
Zip Code215400
Phone86-512-53577866
Company Executives
- Name
- Position
- Salary
- Dr. Zheng Wei, PhD
- Chief Executive Officer and Director
- --
- Steven Chan
- Chief Financial Officer
- --
- Dr. Wubin Pan, PhD
- Chairman of the Board and President
- --
- Dr. Kleanthis G. Xanthopoulos,PhD
- Lead Independent Director
- --
- Karen J. Wilson
- Independent Director
- --
- Jean I. Liu
- Independent Director
- --
- Dr. Kan Chen, PhD
- Independent Director
- --
- James Z. Huang
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
